Assoc. Prof. MÜÇTEBA ENES YAYLA

Publication Network

Articles 53

1. Turkish Society for Rheumatology 2026 vaccine recommendations for adult rheumatology patients Türkiye Romatoloji Derneği 2026 erişkin romatoloji hastalarında aşı önerileri

İlbay A., USLU E., SEZER S., YAYLA M. E., Kaşkari D., Usta A., et al.

Journal of Turkish Society For Rheumatology , vol.18, no.2, pp.150-166, 2026 (Scopus, TRDizin)

2. Comparative analysis of inflammation and fever of unknown origin: Diagnostic processes and etiological spectrum

Özden İ., YAYLA M. E., SEZER S., USLU E., ATEŞ A., TURGAY T. M.

Medicine , vol.105, no.26, 2026 (SCI-Expanded, Scopus)

3. Predictive Factors for Relapse in Still's Disease: A Retrospective Cohort Study of Clinical and Laboratory Biomarkers

ÇAKIR İ. Y., ERDEN A., Mahmutoğlu Y., Kardaş R. C., USLU E., BÖLEK E. Ç., et al.

Clinical and Translational Science , vol.19, no.6, 2026 (SCI-Expanded, Scopus)

4. Interstitial Pneumonia with Autoimmune Features from the Rheumatologists’ Perspective; Single Center Experience

USLU E., Sahin D., Ilbay A., Yilmaz R., Gaydan A., Govec Giynas N., et al.

Diagnostics , vol.16, no.2, 2026 (SCI-Expanded, Scopus)

5. Deep Learning Performance in Analyzing Nailfold Videocapillaroscopy Images in Systemic Sclerosis

Yayla M. E., Aydın A., Kılıçaslan M., Kalkan M., Güzel M. S., Shikhaliyeva A., et al.

DIAGNOSTICS , vol.15, no.22, 2025 (SCI-Expanded, Scopus)

6. Malignancy-associated risk factors in patients with systemic sclerosis

Baysal S., Şahin D., Sezer S., Yayla M. E., Uslu E., Ateş A., et al.

Journal of Scleroderma and Related Disorders , vol.10, no.3, pp.518-522, 2025 (ESCI, Scopus)

7. Is the Development of Hypo-Gammaglobulinemia Associated with Better Treatment Response in Patients with Rheumatoid Arthritis Using Rituximab?

Aydemir Guloksuz E. G., Sezer S., Sahin Eroglu D., Colak S., Kelesoglu Dincer A. B., Yayla M. E., et al.

Journal of clinical medicine , vol.14, no.19, 2025 (SCI-Expanded, Scopus)

8. Ultrasonographic evaluation of hand and wrist joints in patients with systemic sclerosis

Ermancık Z., Yayla M. E., İlbay A., Göveç Gıynaş N., Sezer S., Uslu E., et al.

Journal of Scleroderma and Related Disorders , vol.10, no.3, pp.510-517, 2025 (ESCI, Scopus)

9. Impact of age at disease onset on clinical manifestations and prognosis in systemic lupus erythematosus Sistemik lupus eritematozusta hastalık başlangıç yaşının klinik belirtiler ve prognoz üzerindeki etkisi

Şahin D., Bulat B., Uslu E., Göveç Gıynaş N., Turhan G., Kader M., et al.

Journal of Turkish Society For Rheumatology , vol.17, no.2, pp.60-67, 2025 (Scopus, TRDizin)

10. TRACING THE PATH TO DIAGNOSIS: INITIAL SYMPTOMS AND DELAYS IN SYSTEMIC SCLEROSIS FROM THETURKISH NATIONAL REGISTRY

Guler A. A., Baltaci M. A., Yazgan B. F., Okyar B., Avcu A., UĞURLU Z., et al.

ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus)

11. CLINICAL PREDICTORS OF TREATMENT DISCONTINUATION IN ADULT-ONSET STILL'S DISEASE

ÇAKIR İ. Y., Mahmutoglu Y., Kardas R. C., USLU E., SEZER S., YAYLA M. E., et al.

ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus) Sustainable Development

12. Evaluation of performance of the Still Activity Score for assessment of Adult-onset Still's Disease: Comparative study with Systemic Feature Score and Modified Pouchot-Activity Score Evaluación del desempeño de la puntuación de actividad de Still en la valoración de la enfermedad de Still de inicio en la adultez: un estudio comparativo con la puntuación de las características sistémicas y la puntuación de la actividad modificada de Pouchot

Uslu E., Yayla M. E., Şahin Eroğlu D., Atmaca-Haktaniyan B., Göveç Gıynaş N., Yılmaz R., et al.

Reumatologia Clinica , vol.21, no.2, 2025 (ESCI, Scopus)

13. Rheumatoid Arthritis-Related Lung Disease and Its Association With Mortality

Şahin Eroğlu D., Çolaklar A., Baysal S., Torgutalp M., Baygül A., Sezer S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.30, no.5, pp.177-182, 2024 (SCI-Expanded, Scopus)

14. Serum leukemia inhibitory factor (LIF) levels in patients with Takayasu's and Giant cell arteritis: A cross-sectional study Niveles séricos del factor inhibidor de la leucemia en pacientes con arteritis de Takayasu y de células gigantes, un estudio transversal

Aksoy R., TURGAY T. M., YILMAZ R., SEZER S., YAYLA M. E., USLU E.

Reumatologia Clinica , vol.20, no.6, pp.287-290, 2024 (ESCI, Scopus)

15. Serum leukemia inhibitory factor (LIF) levels in patients with Takayasus and Giant cell arteritis: A cross-sectional study

Aksoy R., TURGAY T. M., YILMAZ R., SEZER S., YAYLA M. E., USLU E.

Reumatología Clínica (English Edition) , vol.20, pp.287-290, 2024 (ESCI)

16. The Performance of 2023 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) Antiphospholipid Syndrome Classification Criteria in a Real-World Rheumatology Department

USTA A., YAYLA M. E., USLU E., SEZER S., US E., ATEŞ A., et al.

Mediterranean Journal of Hematology and Infectious Diseases , vol.16, no.1, 2024 (SCI-Expanded, Scopus)

17. Are there differences in the clinical and laboratory features of patients with seronegative primary Sjögren's syndrome?

Yayla M. E., Aksoy R., Uslu E., Karaman Z., Yılmaz R., Ilbay A., et al.

Turkish journal of medical sciences , vol.54, no.5, pp.956-962, 2024 (SCI-Expanded, Scopus, TRDizin)

18. Investigation of COVID-19 Vaccination and Disease Status in Behçet’s Patients

Yılmaz R., Sezer S., İlbay A., Göveç Gıynaş N., Aydemir Gülöksüz E. G., Gaydan A., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.76, no.3, pp.206-212, 2023 (Peer-Reviewed Journal)

19. Frequency of Helicobacter pylori in Patients With Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance

Aydemir Guloksuz E. G., Sezer S., YAYLA M. E., Sahin Eroglu D., USLU YURTERİ E., Kelesoglu Dincer A. B., et al.

Journal of Clinical Rheumatology , vol.29, no.4, pp.177-182, 2023 (SCI-Expanded, Scopus)

20. The factors predicting development of serious infections in ANCA-associated vasculitis

USLU YURTERİ E., Sezer S., Torgutalp M., YAYLA M. E., Eroglu D. S., Okatan I. E., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , vol.40, no.2, 2023 (SCI-Expanded, Scopus)

21. Audiological involvement in patients with systemic sclerosis

Turan K., Yayla M. E., Arslan M., Tokgoz Yilmaz S., Okatan E., Turgay M., et al.

MODERN RHEUMATOLOGY , vol.32, no.6, pp.1094-1101, 2022 (SCI-Expanded, Scopus)

22. Indications and risk factors for hospitalization in patients with primary Sjogren syndrome: experience from a tertiary center in Turkey

Yayla M. E., ŞAHİN EROĞLU D., USLU YURTERİ E., Dincer A. B. K., Sezer S., AYDEMİR GÜLÖKSÜZ E. G., et al.

CLINICAL RHEUMATOLOGY , vol.41, no.5, pp.1457-1463, 2022 (SCI-Expanded, Scopus)

23. Prognostic factors for relapse and poor outcome in neuro-Behcet's syndrome: results from a clinical long-term follow-up of a single centre

ŞAHİN EROĞLU D., Torgutalp M., YÜCESAN C., Sezer S., Yayla M. E., BOYVAT A., et al.

JOURNAL OF NEUROLOGY , vol.269, no.4, pp.2046-2054, 2022 (SCI-Expanded, Scopus)

24. Fetal exposure to canakinumab: a report of three pregnancies

Ilgen U., Eyupoglu S., Yayla M. E., KÜÇÜKŞAHİN O.

CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1261-1263, 2022 (SCI-Expanded, Scopus)

25. Analysis of vascular involvement in 460 patients with Behc , et's syndrome: Clinical characteristics and associated factors

Torgutalp M., Şahin Eroğlu D., Sezer S., Yayla M. E., Karataş G., Uslu Yurteri E., et al.

JOINT BONE SPINE , vol.89, no.2, 2022 (SCI-Expanded, Scopus)

26. Patients characteristics in Behcet's Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases

Torgutalp M., Eroglu D. S., Sezer S., Yayla M. E., Karatas G., Ozel E. M., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , vol.51, no.1, pp.50-58, 2022 (SCI-Expanded, Scopus)

27. RITUXIMAB EXPERIENCE FROM A SINGLE CENTRE FOR PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Eroglu D. S., Colaklar A., Baysal S., Torgutalp M., Baygul A., YAYLA M. E., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.39, no.3, 2022 (SCI-Expanded, Scopus)

28. Causes of severe infections in patients with systemic sclerosis and associated factors

YAYLA M. E., USLU YURTERİ E., USLU YURTERİ E., Sahin D., Sezer S., Dincer A. B. K., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.6, pp.1881-1888, 2022 (SCI-Expanded, Scopus, TRDizin)

29. Interstitial Lung Disease in Systemic Sclerosis: A Single-center Retrospective Analysis

Yayla M. E., Balci G., USLU YURTERİ E., ŞAHİN EROĞLU D., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., et al.

CURRENT RHEUMATOLOGY REVIEWS , vol.18, no.2, pp.150-156, 2022 (ESCI, Scopus)

30. Can Subclinical Atherosclerosis Be Assessed More Precisely in Behcet Syndrome Patients by Using a Particular Cutoff Value for Carotid Intima Media Thickness?

Uslu Yurteri E., Üstüner E., Torgutalp M., Yayla M. E., Okatan I. E., Sezer S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.28, no.1, 2022 (SCI-Expanded, Scopus)

31. Clinical characteristics of pulmonary artery involvement in patients with Behcet's syndrome: single-centre experience of 61 patients

ŞAHİN EROĞLU D., Torgutalp M., Baysal S., ÇOLAKLAR A., Sezer S., Yayla M. E., et al.

CLINICAL RHEUMATOLOGY , vol.40, no.10, pp.4127-4134, 2021 (SCI-Expanded, Scopus)

32. The Importance of Lower Extremity Vein Wall Thickness in Patients with Behcet's Syndrome

Kocabay H. E., YAYLA M. E., ÜSTÜNER E., Yurteri E. U., Guloksuz E. A., Sezer S., et al.

ARTHRITIS & RHEUMATOLOGY , vol.73, pp.3915-3917, 2021 (SCI-Expanded, Scopus)

33. Serum-Beta-2-Mikroglobulin-level bei Patienten mit rheumatoider Arthritis und ihre Beziehung zur Krankheitsaktivitat: Kann es als Krankheitsaktivitatsmarker verwendet werden?

Dincer A. B. K., Torgutalp M., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., USLU YURTERİ E., et al.

AKTUELLE RHEUMATOLOGIE , vol.46, no.3, pp.297-304, 2021 (SCI-Expanded, Scopus)

34. CLINICAL CHARACTERISTICS OF THE PULMONARY ARTERY INVOLVEMENT IN PATIENTS WITH BEHCET'S SYNDROME: A SINGLE-CENTRE EXPERIENCE OF 61 PATIENTS

Eroglu D. S., Torgutalp M., Baysal S., Colaklar A., Sezer S., Yayla M. E., et al.

ANNALS OF THE RHEUMATIC DISEASES , pp.949-950, 2021 (SCI-Expanded, Scopus)

35. Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels

Torgutalp M., Yayla M. E., Eroglu D. S., Dincer A. B. K., Yurteri E., Okatan I. E., et al.

Mediterranean Journal of Rheumatology , vol.32, no.1, pp.56-65, 2021 (Scopus) Sustainable Development

36. Share Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels.

TORĞUTALP M., YAYLA M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., USLU YURTERİ E., OKATAN İ. E., et al.

MEDITERRANEAN JOURNAL OF RHEUMATOLOGY (MJR) , vol.32, no.1, pp.56-65, 2021 (Scopus)

37. High mobility group box-1 levels may be associated with disease activity of Behcet's disease

Donmez Guler D., Kelesoglu Dincer A. B., KARAHAN Z. C., Guler H. S., Yayla M. E., Sezer S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.5, pp.2690-2697, 2021 (SCI-Expanded, Scopus, TRDizin)

38. Early onset primary Sjogren syndrome, clinical and laboratory characteristics

Yayla M. E., Karaman Z., Torgutalp M., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., et al.

CLINICAL RHEUMATOLOGY , vol.39, no.9, pp.2689-2696, 2020 (SCI-Expanded, Scopus)

39. Romatoid artrit hastalarında serum gebelikle ilişkiliplazma protein-A düzeylerinin incelenmesi

Torgutalp M., DOĞAN Ö., Yayla M. E., Eroğlu D. Ş., Dinçer A. B. K., SEZER S., et al.

Ulusal Romatoloji Dergisi , vol.12, no.2, pp.45-50, 2020 (Peer-Reviewed Journal)

40. Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features

Yayla M. E., Torgutalp M., Okatan I. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., Dincer A. B. K., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.26, no.3, pp.83-86, 2020 (SCI-Expanded, Scopus)

41. İdiyopatik retroperitoneal fibrozis: 17 olguluk tek merkez deneyimi

Keleşoğlu Dinçer A. B., Sezer S., Aydemir Gülöksüz E. G., Yayla M. E., Torgutalp M., Turgay T. M., et al.

Ulusal Romatoloji Dergisi , vol.12, no.1, pp.22-26, 2020 (TRDizin)

42. Vascular Involvement in Behcet's Syndrome May be Associated with Subclinical Atherosclerosis

USLU YURTERİ E., ÜSTÜNER E., Torgutalp M., Yayla M. E., Okatan I. E., Dincer A. B. K., et al.

ARTHRITIS & RHEUMATOLOGY , vol.70, 2018 (SCI-Expanded, Scopus)

43. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus

Ilgen U., Yayla M. E., Ates A., Okatan I. E., Yurteri E., Torgutalp M., et al.

LUPUS , no.4, pp.665-669, 2018 (SCI-Expanded, Scopus)

44. TAKAYASU'S ARTERITIS: EXPERIENCE OF A SINGLE TERTIARY CENTER

Dincer A. B. K., Torgutalp M., Guloksuz E. G. A., Yurteri E. U., Yayla M. E., Okatan I. E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , no.1, 2018 (SCI-Expanded, Scopus)

45. A Rare Clinical Presentation of Behçet’s Disease with Life-Threatening Extensive Multiple Thrombosis and Recurrent Cardiac Arrest

Shimbori N., YAYLA M. E., YILDIZ A. E., Keleş Karahacıoğlu D., DÜZGÜN N.

Türkiye Klinikleri Journal of Case Reports , vol.26, no.3, pp.161-165, 2018 (TRDizin)

46. A GOOD MIMIC: PMR - IS PMR THE ACCURATE DIAGNOSIS? A SINGLE-CENTER STUDY

Aydin T., Isikoglu B. D., Koc O., Dincer A. B. K., Torgutalp M., Yayla M. E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , no.1, 2018 (SCI-Expanded, Scopus)

47. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis

Yayla M. E., Ilgen U., Duzgun N.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.1, pp.10-15, 2018 (SCI-Expanded, Scopus, TRDizin)

48. Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations

Ilgen U., Yayla M. E., Duzgun N.

RHEUMATOLOGY INTERNATIONAL , vol.37, no.4, pp.593-598, 2017 (SCI-Expanded, Scopus)

49. Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis

Ilgen U., Yayla M. E., Duzgun N.

CLINICAL RHEUMATOLOGY , vol.36, no.2, pp.367-372, 2017 (SCI-Expanded, Scopus)

50. RAYNAUD FENOMENİ İLE BAŞVURAN HASTALAR İLE BAĞ DOKU HASTALIĞI OLAN HASTALARIN KAPİLLOROSKOPİK VE LABORATUVAR ÖZELLİKLERİNİN KARŞILAŞTIRILMASI

TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., TURGAY T. M., et al.

RAED DERGİSİ , vol.8, pp.56, 2016 (TRDizin)

51. ATEŞİN NADİR BİR NEDENİ MEZENTERİK PANNİKÜLİT

KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., TORĞUTALP M., YAYLA M. E., KINIKLI G., TURGAY T. M., et al.

RAED DERGİSİ , vol.8, pp.106-107, 2016 (TRDizin)

52. ANTİFOSFOLİPİD ANTİKOR BİRLİKTELİĞİ OLAN VE OLMAYAN SİSTEMİK LUPUS ERİTEMATOZUSLU HASTALARIN AYIRDEDİCİ KLİNİK VE LABORATUVAR ÖZELLİKLERİ

YAYLA M. E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.

RAED DERGİSİ , vol.8, pp.142, 2016 (Peer-Reviewed Journal)

53. PULMONER TUTULUMLU PRİMER SİSTEMİK SKLEROZDA SERUM PROKALSİTONİN DÜZEYİ ENFEKSİYÖZ PULMONER HASTALIKLARDAN AYIRDETTİRİCİ MİDİR

OKATAN İ. E., KINIKLI S., TORĞUTALP M., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.

RAED DERGİSİ , vol.8, pp.75-76, 2016 (TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences 30

1. CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PRIMARY SJÖGREN’S SYNDROME: A SINGLE CENTER EXPERIENCE FROM TURKEY

KARAMAN ONGUN Z., YAYLA M. E., SEZER S., İLBAY A., GÖVEÇ GIYNAŞ N., GAYDAN A., et al.

EULAR 2024 congress, Austria, 12 - 15 June 2024, vol.83, pp.1698-1699, (Summary Text)

2. Characteristics of Idiopathic Inflammatory Myopathy Patients with Interstitial Lung Disease: Results of A Single-Center From Turkey

İLBAY A., USLU E., GÖVEÇ GIYNAŞ N., YAYLA M. E., ŞAHİN EROĞLU D., GAYDAN A., et al.

EULAR 2024 congress, Austria, 12 June 2024, vol.83, pp.1378, (Summary Text)

3. EVALUATION OF CLINICAL CHARACTERISTICS OF BEHÇET SYNDROME PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A SINGLE CENTER EXPERIENCE FROM TURKEY

USLU E., SEZER S., İLBAY A., GÖVEÇ GIYNAŞ N., GAYDAN A., MAHMUTOĞLU Y., et al.

EULAR 2024 congress, Austria, 12 June 2024, vol.83, pp.1250, (Summary Text)

4. KARDİYAK TAMPONAD GELİŞEN SİSTEMİK SKLEROZ HASTASI: OLGU SUNUMU

Mahmutoğlu Y., Yayla M. E., Ateş A., Turgay T. M.

SİSTEMİK SKLEROZ SEMPOZYUMU-4, Ankara, Turkey, 19 - 21 April 2024, pp.45-46, (Full Text)

5. The Importance of Lower extremity vein wall thickness in patients with Behcet's Syndrome

Kocabay H. E., Yayla M. E., Üstüner E., Uslu Yurteri E., Aydemir Gülöksüz E. G., Sezer S., et al.

American College of Rheumatology Meeting Abstracts, Washington, United States Of America, 03 November 2021, (Summary Text)

6. Romatoid artrit ilişkili akciğer hastalığı prevalansı ve mortalite ile ilişkili faktörler: Tek merkez deneyimi

ŞAHİN EROĞLU D., ÇOLAKLAR A., Baysal S., TORĞUTALP M., BAYGÜL A., SEZER S., et al.

XXI. Ulusal Romatoloji Kongresi 29 Eylül-3 Ekim 2021, Antalya, Antalya, Turkey, 29 September - 03 October 2021, (Summary Text)

7. Behçet Hastalarının Klinik Özellikleriyle Sınıf 1 HLA Grupları Arasındaki İlişkinin İncelenmesi-Hla B51 Ve C16 Behçet Hastalarında Vaskuler Tutulum içın Risk Faktorü Olabilir mi?

YILMAZ R., Aksoy R., SEZER S., AYDEMİR GÜLÖKSÜZ E. G., KELEŞOĞLU DİNÇER A. B., YAYLA M. E., et al.

Ankara Romatoloji Toplantısı, 10-12 Eylül 2021, Sapanca Türkiye., Sapanca, Turkey, 10 - 12 September 2021, (Summary Text)

8. POS0597 Effects Of Rıtuxımab In Patıents Wıth Rheumatoıd Arthrıtıs-Related Interstıtıal Lung Dısease: A Sıngle-Centre Experıence From Turkey.

ŞAHİN EROĞLU D., ÇOLAKLAR A., Baysal S., TORĞUTALP M., BAYGÜL A., YAYLA M. E., et al.

Annual European Congress of Rheumatology- EULAR 2021, 01 June 2021, vol.80, pp.532-533, (Summary Text)

9. Erken başlangıçlı primer Sjögren sendromu, klinik ve laboratuvar özellikleri

YAYLA M. E., KARAMAN ONGUN Z., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., SEZER S., et al.

20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

10. ANCA ilişkili vaskülitlerde enfeksiyon riski

USLU YURTERİ E., SEZER S., TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., et al.

20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

11. Vasküler Behçet hastalarının demografik ve klinik karakteristiklerinin incelenmesi: 424 hastanın retrospektif analizi.

TORĞUTALP M., ŞAHİN EROĞLU D., SEZER S., YAYLA M. E., TURGAY T. M., KINIKLI G., et al.

20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

12. Behçet hastalarının klinik ve demografik karakteristikleri

ŞAHİN EROĞLU D., TORĞUTALP M., SEZER S., KOSKU H., Özel E. M., YAYLA M. E., et al.

20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

13. FRI0295 Evaluation Of Clinical Characteristics In Behcet Syndrome By Gender And Age; A Single Center Experience with 665 Patients

TORĞUTALP M., SEZER S., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., ŞAHİN EROĞLU D., et al.

Annual European Congress of Rheumatology- EULAR 2019, Madrid, Spain, 12 - 15 June 2019, vol.78, pp.828-829, (Summary Text)

14. BEHÇET SENDROMUNDA VASKÜLER TUTULUM VE SUBKLİNİK ATEROSKLEROZARASINDAKİ İLİŞKİ

USLU YURTERİ E., ÜSTÜNER E., TORĞUTALP M., Yayla M. E., OKATAN İ. E., KELEŞOĞLU DİNÇER A. B., et al.

19. Ulusal Romatoloji Kongresi, Muğla, Turkey, 26 - 30 September 2018, (Summary Text)

15. BEHÇET HASTALARINDA SERUM CALPROTECTİN DÜZEYİ İLE KLİNİK VE LABORATUVAROLARAK DEĞERLENDİRİLEN HASTALIK AKTİVİTE PARAMETRELERİ ARASINDAKİİLİŞKİNİN İNCELENMESİ

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., USLU YURTERİ E., OKATAN İ. E., et al.

19. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

16. Primer Sjögren sendromunda interlökin–35 düzeyi ve klinik bulgular ile ilişkisi.

YAYLA M. E., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., et al.

19.Ulusal Romatoloji Kongresi 26-30 Eylül 2018 Bodrum., Bodrum, Turkey, 26 - 30 September 2018, (Summary Text)

17. Ankilozan spondilit ve romatoid artrit hastalarında b2- mikroglobulin düzeyi ve hastalık aktivitesi ile olan ilişkisi

KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., YAYLA M. E., TORĞUTALP M., SEZER S., USLU YURTERİ E., et al.

11. Anadolu Romatoloji Günleri, Antalya, Turkey, 2 - 06 May 2018, (Summary Text)

18. AB0734 Serum il-35 levels in systemic sclerosis and relationship with clinical features

YAYLA M. E., TORĞUTALP M., OKATAN İ. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., KELEŞOĞLU DİNÇER A. B., et al.

EULAR 2018, Amsterdam, Netherlands, 13 - 16 June 2018, (Summary Text)

19. THU0103 Evaluation of serum Β-2 microglobulin levels and its relationship with disease activity in rheumatoid arthritis

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., GÜLÖKSÜZ E. G., YAYLA M. E., USLU YURTERİ E., OKATAN İ. E., et al.

EULAR 2018, Amsterdam, Netherlands, 13 - 16 June 2018, (Summary Text)

28. Comparison of capillaroscopic and laboratory features of patients with Raynaud's phenomenon and patients with connective tissue disease

KINIKLI G., TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.

MIRCIM 2017 & TIHUD-TIP Joint Meeting, Poland, 11 - 14 May 2017, pp.27, (Summary Text)

29. VASKÜLER BEHÇET HASTALARININ KARAKTERİSTİK ÖZELLİKLERİ

ATEŞ A., OKATAN İ. E., TORĞUTALP M., USLU YURTERİ E., BAŞ AKSU Ö., YALÇINER M., et al.

ULUSAL ROMATOLOJİ KONGRESİ, Turkey, 24 - 30 October 2016, vol.8, pp.156-157, (Summary Text)

30. SYSTEMIC LUPUS ERYTHEMATOSUS WITH AND WITHOUT ANTIPHOSPHOLIPID ANTIBODIES DISCRIMINATIVE CLINICAL LABORATORY FEATURES

İLGEN U., ATEŞ A., YAYLA M. E., USLU YURTERİ E., TURGAY T. M., KINIKLI G.

15.INTERNATIONAL CONGRESS ON ANTIPHOSPHOLLIPID ANTIBODIES, 21 - 24 September 2016, (Summary Text)

Metrics

Publication

180

Publication (WoS)

Publication (Scopus)

Citation (WoS)

238

H-Index (WoS)

Citation (Scopus)

260

H-Index (Scopus)

Citation (Scholar)

151

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sobiad)

H-Index (Sobiad)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sobiad)

H-Index (Sobiad)

Citation (Sum Other)

Project

Thesis Advisory

Open Access